Fig. 3From: Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP studyChange from Day 1 in VAS score at rest (mITT population, post hoc analysis). Data are mean ± SD. P values for intergroup differences were calculated by t-test. mITT, modified intention-to-treat; SD, standard deviation; VAS, Visual Analogue ScaleBack to article page